Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT04084548
PHASE3

Perioperative Lidocaine and Ketamine in Abdominal Surgery

Sponsor: The Cleveland Clinic

View on ClinicalTrials.gov

Summary

The investigators propose to test the hypothesis that perioperative infusions of lidocaine and/or ketamine reduce opioid consumption and pain scores in adults recovering from elective inpatient abdominal surgery.

Official title: Lidocaine and Ketamine in Abdominal Surgery

Key Details

Gender

All

Age Range

18 Years - 80 Years

Study Type

INTERVENTIONAL

Enrollment

420

Start Date

2019-10-15

Completion Date

2025-12

Last Updated

2025-05-21

Healthy Volunteers

Yes

Interventions

DRUG

Lidocaine and ketamine

Perioperative lidocaine and ketamine infusion (see below for dosages and timings)

DRUG

Lidocaine

Perioperative lidocaine infusion (1.5 mg/kg bolus followed by an infusion of 2 mg/kg/hour based on actual body weight; the bolus and infusion will be started after anesthesia induction and before surgical incision, and continued until 1 hour after transfer from the operating room to the PACU)

DRUG

Ketamine

Perioperative ketamine infusion (0.5 mg/kg bolus followed by an infusion of 0.3 mg/kg/hour based on actual body weight; the bolus and infusion will be started after anesthesia induction and before surgical incision, and continued until 1 hour after transfer from the operating room to the PACU)

DRUG

Placebo

Perioperative placebo infusion (normal saline)

Locations (1)

Cleveland Clinic Florida

Weston, Florida, United States